Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

When should pharmacologic therapies be used for uremic pericarditis?

Osamah Badwan, MD, Warren Skoza, MD, Lorenzo Braghieri, MD, Ian Persits, DO and Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC
Cleveland Clinic Journal of Medicine September 2023, 90 (9) 549-554; DOI: https://doi.org/10.3949/ccjm.90a.23003
Osamah Badwan
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Warren Skoza
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Braghieri
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Persits
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan L. Klein
Director, Center for the Diagnosis and Treatment of Pericardial Diseases, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 90 no. 9 549-554
DOI 
https://doi.org/10.3949/ccjm.90a.23003
PubMed 
37657836

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online September 1, 2023.

Copyright & Usage 
Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Osamah Badwan, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Warren Skoza, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Lorenzo Braghieri, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Ian Persits, DO
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC⇑
  1. Director, Center for the Diagnosis and Treatment of Pericardial Diseases, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Address:
    Allan L. Klein, MD, Department of Cardiovascular Medicine, J1-5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kleina{at}ccf.org
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 90 (9)
Cleveland Clinic Journal of Medicine
Vol. 90, Issue 9
1 Sep 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
When should pharmacologic therapies be used for uremic pericarditis?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
When should pharmacologic therapies be used for uremic pericarditis?
Osamah Badwan, Warren Skoza, Lorenzo Braghieri, Ian Persits, Allan L. Klein
Cleveland Clinic Journal of Medicine Sep 2023, 90 (9) 549-554; DOI: 10.3949/ccjm.90a.23003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
When should pharmacologic therapies be used for uremic pericarditis?
Osamah Badwan, Warren Skoza, Lorenzo Braghieri, Ian Persits, Allan L. Klein
Cleveland Clinic Journal of Medicine Sep 2023, 90 (9) 549-554; DOI: 10.3949/ccjm.90a.23003
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • PATHOPHYSIOLOGY OF UREMIC PERICARDITIS
    • SIGNS AND SYMPTOMS
    • RENAL REPLACEMENT THERAPY
    • GUIDING THERAPY
    • PERICARDIAL INTERVENTIONS
    • PHARMACOLOGIC THERAPY IN PATIENTS WITH RESIDUAL KIDNEY FUNCTION
    • CONSIDERATIONS IN END-STAGE RENAL DISEASE WITHOUT RESIDUAL KIDNEY FUNCTION
    • BIOLOGIC AGENTS
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
  • Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
  • Does my adult patient need a measles vaccine?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Cardiology
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire